2,181 followers
Ofatumumab for double-refractory chronic lymphocytic #leukemia - outcomes & cost effectiveness https://t.co/zHPxo6l8Pu
Ofatumumab for double-refractory chronic lymphocytic #leukemia - outcomes & cost effectiveness https://t.co/zHPxo6l8Pu
Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory… https://t.co/o7pjeJC1x7 https://t.co/pDMSwrS4ul